Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
69 hedge funds and large institutions have $542M invested in Portola Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
14% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 22
12% more capital invested
Capital invested by funds: $485M → $542M (+$56.5M)
11% more funds holding
Funds holding: 62 → 69 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
+$16.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.16M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$9.71M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$7.51M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.98M |
| 4 |
O
OrbiMed
New York
|
-$3.65M |
| 5 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
-$2.46M |
PTLA Hedge Fund Activity: Q3 2013 in Review
69 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2013, worth a combined $542M — up 12% from $485M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PTLA positions and 5 closed out — a net gain of 7 holders — while 25 added to existing stakes and 22 trimmed.
The largest buyer was Ontario Teachers' Pension Plan Board, adding an estimated $16.1M. The largest seller was Deerfield Management, cutting an estimated $9.71M.
- 69 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2013, up from 62 in Q2 2013.
- Funds reported $542M of Portola Pharmaceuticals, Inc. stock for Q3 2013, up 12% quarter-over-quarter.
- 12 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2013 and 5 closed out, a net change of +7 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q3 2013 was Ontario Teachers' Pension Plan Board, an estimated $16.1M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q3 2013 was Deerfield Management, an estimated $9.71M sold.
Based on aggregated 13F filings for Q3 2013.